148 related articles for article (PubMed ID: 16626787)
1. Cinnamaldehyde reduction of platelet aggregation and thrombosis in rodents.
Huang J; Wang S; Luo X; Xie Y; Shi X
Thromb Res; 2007; 119(3):337-42. PubMed ID: 16626787
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic activity of a newly synthesized coumarin derivative 3-(5-hydroxy-2,2-dimethyl-chroman-6-yl)-N-{2-[3-(5-hydroxy-2,2-dimethyl-chroman-6-yl)-propionylamino]-ethyl}-propionamide.
Jain M; Surin WR; Misra A; Prakash P; Singh V; Khanna V; Kumar S; Siddiqui HH; Raj K; Barthwal MK; Dikshit M
Chem Biol Drug Des; 2013 Apr; 81(4):499-508. PubMed ID: 23534412
[TBL] [Abstract][Full Text] [Related]
3. The pyrrolidinoindoline alkaloid Psm2 inhibits platelet aggregation and thrombus formation by affecting PI3K/Akt signaling.
Su XL; Su W; Wang Y; Wang YH; Ming X; Kong Y
Acta Pharmacol Sin; 2016 Sep; 37(9):1208-17. PubMed ID: 27424653
[TBL] [Abstract][Full Text] [Related]
4. Effect of vintoperol on platelet aggregation and experimental thrombosis.
Csomor K; Kárpáti E
Arzneimittelforschung; 1994 Jan; 44(1):36-40. PubMed ID: 8135876
[TBL] [Abstract][Full Text] [Related]
5. Neferine exerts its antithrombotic effect by inhibiting platelet aggregation and promoting dissociation of platelet aggregates.
Zhou YJ; Xiang JZ; Yuan H; Liu H; Tang Q; Hao HZ; Yin Z; Wang J; Ming ZY
Thromb Res; 2013 Aug; 132(2):202-10. PubMed ID: 23773522
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet and antithrombotic activities of NQ301, 2-chloro-3-(4-acetophenyl)-amino-1,4-naphthoquinone.
Kang WS; Ryu CK; Chung KH; Ko MW; Joo JC; Yuk DY; Yoo HS; Yun YP
Biol Pharm Bull; 1999 Dec; 22(12):1284-7. PubMed ID: 10746156
[TBL] [Abstract][Full Text] [Related]
7. Antithrombotic and antiplatelet activities of 2-chloro-3-[4-(ethylcarboxy)-phenyl]-amino-1,4-naphthoquinone (NQ12), a newly synthesized 1,4-naphthoquinone derivative.
Yuk DY; Ryu CK; Hong JT; Chung KH; Kang WS; Kim Y; Yoo HS; Lee MK; Lee CK; Yun YP
Biochem Pharmacol; 2000 Oct; 60(7):1001-8. PubMed ID: 10974210
[TBL] [Abstract][Full Text] [Related]
8. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice.
Teng CM; Wu CC; Ko FN; Lee FY; Kuo SC
Eur J Pharmacol; 1997 Feb; 320(2-3):161-6. PubMed ID: 9059849
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic activities of green tea catechins and (-)-epigallocatechin gallate.
Kang WS; Lim IH; Yuk DY; Chung KH; Park JB; Yoo HS; Yun YP
Thromb Res; 1999 Nov; 96(3):229-37. PubMed ID: 10588466
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of J78, a newly synthesized 1,4-naphthoquinone derivative, on experimental thrombosis and platelet aggregation.
Jin YR; Ryu CK; Moon CK; Cho MR; Yun YP
Pharmacology; 2004 Apr; 70(4):195-200. PubMed ID: 15001820
[TBL] [Abstract][Full Text] [Related]
11. Effect of traditional Uyghur medicine abnormal Savda Munziq extract on rabbit platelet aggregation in vitro and rat arteriovenous shunt thrombosis in vivo.
Umar A; Yimin W; Tohti I; Upur H; Berké B; Moore N
J Ethnopharmacol; 2015 Jan; 159():184-8. PubMed ID: 25449463
[TBL] [Abstract][Full Text] [Related]
12. The in vitro and in vivo pharmacological profiles of a platelet glycoprotein IIb/IIIa antagonist, NSL-9403.
Katada J; Takiguchi Y; Muramatsu M; Fujiyoshi T; Uno I
Thromb Res; 1997 Oct; 88(1):27-40. PubMed ID: 9336871
[TBL] [Abstract][Full Text] [Related]
13. Effect of hsien-ho-t'sao (Agrimonia pilosa) on experimental thrombosis in mice.
Hsu MF; Young JH; Wang JP; Teng CM
Am J Chin Med; 1987; 15(1-2):43-51. PubMed ID: 3687839
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of Bulnesia sarmienti aqueous extract on agonist-induced platelet activation and thrombus formation involves mitogen-activated protein kinases.
Kamruzzaman SM; Endale M; Oh WJ; Park SC; Kim KS; Hong JH; Kwak YS; Yun BS; Rhee MH
J Ethnopharmacol; 2010 Aug; 130(3):614-20. PubMed ID: 20558266
[TBL] [Abstract][Full Text] [Related]
15. The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties.
Sugidachi A; Asai F; Ogawa T; Inoue T; Koike H
Br J Pharmacol; 2000 Apr; 129(7):1439-46. PubMed ID: 10742300
[TBL] [Abstract][Full Text] [Related]
16. Total steroidal alkaloids from Veratrum patulum L. Inhibit platelet aggregation, thrombi formation and decrease bleeding time in rats.
Song Q; Wang S; Zhao W
J Ethnopharmacol; 2012 May; 141(1):183-6. PubMed ID: 22366682
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet and antithrombotic activities of CP201, a newly synthesized 1,4-naphthoquinone derivative.
Jin YR; Hwang KA; Cho MR; Kim SY; Kim JH; Ryu CK; Son DJ; Park YH; Yun YP
Vascul Pharmacol; 2004 Feb; 41(1):35-41. PubMed ID: 15135330
[TBL] [Abstract][Full Text] [Related]
18. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
[TBL] [Abstract][Full Text] [Related]
19. Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilization.
Chang MC; Uang BJ; Tsai CY; Wu HL; Lin BR; Lee CS; Chen YJ; Chang CH; Tsai YL; Kao CJ; Jeng JH
Br J Pharmacol; 2007 Sep; 152(1):73-82. PubMed ID: 17641677
[TBL] [Abstract][Full Text] [Related]
20. Mouse antithrombotic assay. Inhibition of platelet thromboembolism by disintegrins.
Beviglia L; Poggi A; Rossi C; McLane MA; Calabrese R; Scanziani E; Cook JJ; Niewiarowski S
Thromb Res; 1993 Aug; 71(4):301-15. PubMed ID: 8236159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
